Cargando…
Sales for anti-angiogenic drugs
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503515/ https://www.ncbi.nlm.nih.gov/pubmed/28498802 http://dx.doi.org/10.18632/oncotarget.17373 |
| _version_ | 1783249112636850176 |
|---|---|
| author | Ribatti, Domenico |
| author_facet | Ribatti, Domenico |
| author_sort | Ribatti, Domenico |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5503515 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55035152017-07-11 Sales for anti-angiogenic drugs Ribatti, Domenico Oncotarget Editorial Impact Journals LLC 2017-04-23 /pmc/articles/PMC5503515/ /pubmed/28498802 http://dx.doi.org/10.18632/oncotarget.17373 Text en Copyright: © 2017 Ribatti http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Editorial Ribatti, Domenico Sales for anti-angiogenic drugs |
| title | Sales for anti-angiogenic drugs |
| title_full | Sales for anti-angiogenic drugs |
| title_fullStr | Sales for anti-angiogenic drugs |
| title_full_unstemmed | Sales for anti-angiogenic drugs |
| title_short | Sales for anti-angiogenic drugs |
| title_sort | sales for anti-angiogenic drugs |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503515/ https://www.ncbi.nlm.nih.gov/pubmed/28498802 http://dx.doi.org/10.18632/oncotarget.17373 |
| work_keys_str_mv | AT ribattidomenico salesforantiangiogenicdrugs |